FindTrial
Sign In

The Efficacy and Health Economic Evaluation of Integrated Traditional Chinese and Western Medicine in Patients with Severe Acute Pancreatitis

The Efficacy and Health Economic Evaluation of Integrated Traditional Chinese and Western Medicine in Patients with Severe Acute Pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004403
Enrollment
Unknown
Registered
2014-03-21
Start date
2008-03-12
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe acute pancreatitis

Interventions

study group:Western medicine + traditional Chinese medicine
control group:Western medicine + placebo of traditional Chinese medicine

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years; 2. confirmed diagnosis of SAP; 3. within the first 7 days after the onset of abdominal pain.

Exclusion criteria

Exclusion criteria: 1. pregnant or lactating women; 2. malignancy; 3. pre-death state (possible death within 12 h after enrolment); 4. other TCM treatment prior to hospital admission.

Design outcomes

Primary

MeasureTime frame
the length of the hospital stay, total hospitalisation expenses, operation rate and mortality;—

Secondary

MeasureTime frame
organ complications, duration of enteroparalysis, infection, intensive care unit stay and use of respirators;—

Countries

China

Contacts

Public ContactQing Xia

West China Hospital, Sichuan University

xiaqing@medmail.com.cn+86 18980601723

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026